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ABSTRACT
To successfully infect plants, viruses must counter-
act small RNA-based host defense responses.
During infection of Arabidopsis, Cauliflower mosaic
pararetrovirus (CaMV) is transcribed into
pregenomic 35S and subgenomic 19S RNAs. The
35S RNA is both reverse transcribed and also used
as an mRNA with highly structured 600nt leader.
We found that this leader region is transcribed
into long sense- and antisense-RNAs and spawns
a massive quantity of 21, 22 and 24nt viral small
RNAs (vsRNAs), comparable to the entire comple-
ment of host-encoded small-interfering RNAs and
microRNAs. Leader-derived vsRNAs were detected
bound to the Argonaute 1 (AGO1) effector protein,
unlike vsRNAs from other viral regions. Only negli-
gible amounts of leader-derived vsRNAs were
bound to AGO4. Genetic evidence showed that all
four Dicer-like (DCL) proteins mediate vsRNA bio-
genesis, whereas the RNA polymerases Pol IV, Pol
V, RDR1, RDR2 and RDR6 are not required for this
process. Surprisingly, CaMV titers were not
increased in dcl1/2/3/4 quadruple mutants that ac-
cumulate only residual amounts of vsRNAs. Ectopic
expression of CaMV leader vsRNAs from an
attenuated geminivirus led to increased accumula-
tion of this chimeric virus. Thus, massive production
of leader-derived vsRNAs does not restrict viral
replication but may serve as a decoy diverting the
silencing machinery from viral promoter and coding
regions.
INTRODUCTION
Multicellular eukaryotes have evolved conserved, small
RNA (sRNA)-generating pathways that regulate gene ex-
pression and silence transposons (1,2). In plants and some
animals, sRNA pathways also have crucial functions in
antiviral defense (3,4). Viral small RNA (vsRNA)
duplexes processed from longer double-stranded RNAs
(dsRNA) feed a cycle of viral RNA degradation, which
spawns silencing signals that hinder viral spread (4). As a
counter-defense, viruses express silencing-suppressor
proteins able to block RNA silencing mechanisms of the
host. Demonstrated activities of these suppressors include
dsRNA binding to block vsRNA biogenesis, sequestration
of vsRNA duplexes and inhibition of Argonaute protein
(AGO)-mediated cleavage of viral transcripts (5).
The diverse silencing-suppression strategies reﬂect re-
dundancy and functional specialization within plant
sRNA pathways (4,5). Arabidopsis expresses at least
three RNA-dependent RNA polymerases (RDR1, 2 and
6) thought to convert aberrant single-stranded RNA into
dsRNA (6) and four Dicer-like (DCL) enzymes that
process dsRNA or structured RNA into 21–24 nt
sRNAs (1). RDR2 is required for the production of en-
dogenous 24 nt, small-interfering RNA (siRNAs) that
direct DNA methylation in plants (7). RDR6 generates
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precursors for 21 nt trans-acting siRNAs that control the
timing of organ development (1). During RNA virus in-
fection, RDR1 and RDR6 have functions in the biogen-
esis or ampliﬁcation of viral dsRNA (8–11), while DCL4
and DCL2 act to process this dsRNA into 21 nt and 22 nt
vsRNAs, respectively (12). Arabidopsis mutants deﬁcient
for multiple DCL proteins are hypersusceptible to RNA
viruses (12–14). The biogenesis of vsRNAs accompanying
DNA virus infection is even more complex. In response to
geminivirus infection, three Arabidopsis DCLs produce
distinct size-classes of vsRNAs and during infection by
the pararetrovirus Cauliﬂower mosaic virus (CaMV), four
DCL enzymes are implicated, including DCL1 (14,15).
DCL1 normally functions to excise plant miRNAs from
hairpin RNA precursors. The particular mechanism of
CaMV replication and structured RNA encoded in its
genome may explain the involvement of all four DCLs
(14,16).
The CaMV genome is transcribed into a more than
genome length, 35S transcript in the nucleus by host
RNA polymerase II (17). A shorter, 19S RNA transcript,
co-terminal with the 35S RNA, is also produced during
CaMV infection. It encodes the multifunctional
transactivator/viroplasmin (TAV) protein, which is a
weak silencing suppressor (18–20). The 35S RNA func-
tions as both a polycistronic mRNA and as the template
for reverse transcription (RT) required for viral genome
replication (21). These functions are controlled by the
600 nt leader sequence that folds into an elongated
hairpin (22–25). Interestingly, the leader region was pre-
viously identiﬁed as a rich source of vsRNAs (14,16).
We performed a global analysis of vsRNA populations
in CaMV-infected Arabidopsis mutants and evaluated the
impact of these vsRNAs on virus replication. Surprisingly,
dcl-mutants that exhibit only minimal vsRNA accumula-
tion did not show hypersusceptibility to CaMV infection.
Massive vsRNA generation from the CaMV leader region,
biased association of leader-derived vsRNAs with the
AGO1 effector protein and the ability of this 600-bp
non-coding sequence to confer enhanced infectivity to a
chimeric geminivirus suggest that it plays a role in viral
counter-defense.
MATERIALS AND METHODS
Arabidopsis mutant lines and virus infection
The drd1-6, drd2-4, and drd3-7 (26), nrpd2a-1 (27), rdr2-1
(7) and rdr6-15 (28) were described previously.
Homozygous rdr2 rdr6 was obtained in the F2 generation
of a cross between rdr2-1 and rdr6-15. Homozygous rdr1
rdr2 rdr6 was obtained in the F2 generation of a cross
between rdr1-1 (7) and the abovementioned rdr2 rdr6
line. Quadruple mutant dcl1/2/3/4 material was obtained
by crossing either dcl1-8 (sin1-2) (29) or dcl1-9 (caf) (30) to
the triple mutant dcl2/3/4 (14). dcl1-9 used in the above
crosses had been introgressed into Col-0 from Ler/Ws
backgrounds by 5 outcrossing. After crossing dcl1 to
dcl2/3/4, F2 individuals of genotype dcl1 (+/) dcl2
(/) dcl3 (/) dcl4 (/) were selected and
self-fertilized. About 25% of resulting F3 progeny were
quadruple homozygous.
Plant growth and inoculation with CaMV strain
CM1841 were done as described previously (14).
Infected plants were harvested 1-month post-inoculation,
unless otherwise stated. Virus DNA titers were measured
by semi-quantitative PCR as described (14) and by
real-time quantitative PCR (qPCR) for viral DNA and
qRT–PCR for polyadenylated viral RNAs. For qRT–
PCR, cDNA was synthesized from 2 mg total RNA using
100 pmol of d(T)16 primer. This mixture was heated to
70C for 10min and chilled on ice for 5min. Then, the
following reagents were added: 4 ml of 5 ﬁrst-strand syn-
thesis buffer [250 mM Tris–HCl (pH 8.3), 375mM KCl,
15mM MgCl2, 0.1M DTT], 2 ml 0.1M DTT, 1 ml 10mM
dNTP mix and 1 ml (200U) Superscript III reverse tran-
scriptase (Invitrogen). The reaction was incubated at 50C
for 1 h and stopped by heating at 95C for 5min.
One-tenth volume of the reaction mix was used for
real-time PCR. Real-time PCR analysis with SYBR
Green (Applied Biosystems, UK) was carried out using
the Applied Biosystems 7500 system. qPCR and qRT–
PCR primers (Supplementary Table S3) speciﬁc for the
virus (the CaMV leader and the TAV gene or the
CaLCuV AC4 gene) and the internal control gene
(ACT2 for qRT–PCR or 18S rDNA for qPCR) were
designed using Beacon designer 2 software (PREMIER
Biosoft International).
Small RNA analysis by Illumina sequencing
Total RNA was isolated from pools of three plants using
the Trizol method as described previously (14). Ten micro-
grams of total RNA for each sample from
mock-inoculated and CaMV-infected wild-type or
mutant plants were taken for preparation of sRNA
libraries following Illumina’s modiﬁed protocol for the
sRNA library construction kit. The 19–30 nt RNA
fraction from total RNA samples was puriﬁed on a 15%
TBE–Urea acrylamide gel. A 50-adenylated single-
stranded adapter was ﬁrst ligated to the 30-end of the
RNA using T4 RNA ligase without ATP followed by a
second single-stranded adapter ligated at the 50-end of the
RNA using T4 RNA ligase in the presence of ATP. The
resulting products were puriﬁed on a 10% TBE–Urea
acrylamide gel before performing the cDNA synthesis
and PCR ampliﬁcation. The resulting libraries were
sequenced on an Illumina Genome Analyzer following
the manufacturer’s protocol.
After trimming the adaptor sequences, the datasets of
all and unique reads were mapped to the reference
genomes of Arabidopsis thaliana Col-0 (NCBI build 8.1)
and CaMV (Genbank V00140) using the Mapping and
Assembly with Qualities (MAQ) program (version 0.7.1)
with a maximum of two mismatches to the reference se-
quences allowed. Reads mapping to several positions on
the references with the same ‘mapping quality’ (i.e.
number of mismatches and quality of the bases generating
the mismatches) were attributed at random to one of them
and attributed a ‘zero’ mapping quality. To account for
the circular virus genome, reads that were not mapped on
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the references were retrieved and mapped with the MAQ
software on the viral junction, built from the last and ﬁrst
50 bases of the viral sequence. The total reads that were
mapped to the reference genomes with zero mismatches
constituted upto 90% in the libraries of a high coverage
and quality run (‘Col-0 mock’, ‘Col-0 CaMV’, ‘rdr1/2/6
CaMV’ and ‘dcl1-8 CaMV’) and 50% in the libraries of
a lower coverage and quality run (‘Col-0 CaMV*’ and
‘dcl2/3/4 CaMV*’) and were taken for further analysis.
For each reference genome and each sRNA size-class
(20–25 nt), we counted once for all reads mapped and
once for all reads mapped with a minimum quality of 10
(which implies uniquely mapped reads) the following:
total number of reads, reads in forward and reverse orien-
tation, reads starting with A, C, G and T (Supplementary
Tables S1 and S2). In the single-base resolution maps of
20, 21, 22, 23, 24 and 25 nt vsRNA (Supplementary Data
SD1), for each viral genome position we have displayed
the number of matches starting at this position in reverse
(last base of the read) and forward (ﬁrst base of the read)
orientations.
RNA blot hybridization
sRNA blot hybridization analysis was performed as in
Blevins et al. (14) using short DNA oligonucleotide
probes listed in Supplementary Table S3.
8S RNA mapping by cRT–PCR
Circularization reverse transcription–PCR (cRT–PCR)
was carried out as described previously (31). Brieﬂy,
decapping was performed on 10 mg of total RNA using
tobacco acid pyrophosphatase (Epicentre Technologies,
Madison, WI, USA) in the presence of RNase inhibitor
RNasin (Promega, Madison, WI, USA). After chloroform
extraction, RNA was precipitated with ethanol and
circularized using T4 RNA ligase 1 (NEB) in the
presence of RNasin. Following extraction with chloro-
form, ligation products were precipitated with ethanol.
Circular RNA was reverse transcribed using
SuperScriptIII reverse transcriptase (Invitrogen) with
either L94_as or L410_s primer (Supplementary Table
S3). The cDNA synthesized with the L410_s primer was
PCR ampliﬁed using Taq DNA polymerase (NEB) with
the L410_s primer together with L13_as or L94_as primers
and cDNA synthesized with the L94_as primer was PCR
ampliﬁed with the L94_as primer together with L410_s or
L514_s primers (Supplementary Table S3). PCR products
were analyzed by agarose gel electrophoresis
(Supplementary Figure S4), excised from the gel, cloned
in pGEM-T Easy vector (Promega) and sequenced. In the
cRT–PCR experiment performed without
pyrophosphatase treatment, 10 mg of total RNA was
directly taken for ligation, while other parameters
remained the same.
Immunopuriﬁcation of AGO proteins and associated
sRNAs
This experiment followed an established protocol (32).
Brieﬂy, Arabidopsis tissue from mock-inoculated and
CaMV-infected plants was ground in liquid nitrogen and
incubated with ice-cold extraction buffer [50 mM Tris–
HCl (pH 7.5), 300mM NaCl, 10mM MgCl2, 0.5%
NP-40, 5mM dithiothreitol (DTT), complete protease in-
hibitor (Roche) and 10mM MG-132 (Sigma)] with agita-
tion for 30min at 4C. Insoluble material was removed by
centrifugation for 15min at 15 300 rpm at 4C. Lysate was
pre-cleaned by incubation with 30 ml of protein A-agarose
beads (Roche) at 4C for 1 h. The 1mL of supernatant was
then incubated overnight at 4C with either 5 ml of normal
rabbit serum (NRS, Sigma), or 5 ml (5 mg IgG) of
anti-AGO1 or anti-AGO4 sera (Agisera) pre-bound to
30 ml protein A-agarose beads. Immunoprecipitates were
washed three times with the extraction buffer.
Immunoprecipitated RNA was puriﬁed using the Trizol
method and analyzed by RNA blot hybridization as
described above. Aliquots of precipitated AGO proteins
were analyzed by western blot.
Construction and testing of the CaLCuV-CaMV leader
chimeric virus
The 612-bp CaMV leader fragment was PCR ampliﬁed
with CamvL_Xho_s and CamvL_Xho_s primers
(Supplementary Table S3), trimmed with XhoI (the site
imbedded into each primer) and cloned into the XhoI
site of the Cabbage leaf curl virus vector
pMTCbLCVA.007 (33) in the antisense orientation. The
resulting chimeric virus CaCLCuV-CamvL was tested for
infectivity on Arabidopsis using biolistic delivery as
described by Blevins et al. (14). As a control, we used
the CaLCuV vector carrying a complete, green ﬂuorescent
protein (GFP) coding sequence of 714 bp inserted between
KpnI and XhoI (CaLCuV-GFP). Accumulation of viral
DNA in infected plants was measured by
semi-quantitative PCR as described earlier (14) and con-
ﬁrmed by qPCR; for PCR primers see Supplementary
Table S3. The vsRNAs derived from the CaMV and
CaLCuV sequences were analyzed by RNA blot hybrid-
ization as described earlier (14) using DNA oligonucleo-
tide probes (Supplementary Table S3).
RESULTS AND DISCUSSION
By ethidium bromide (EtBr) staining of size-separated
RNA, we detected massive quantities of 21–24 nt
RNAs in CaMV-infected Arabidopsis. CaMV-derived
sRNAs appeared to be more abundant in infected plants
than the complement of host sRNAs detected in the
mock-inoculated control (Figure 1A). In contrast, EtBr
staining of RNA from Cabbage leaf curl geminivirus or
Oilseed rape mosaic tobamovirus infections yielded
scarcely detectable levels of sRNAs (data not shown).
Abundant amounts of sRNAs were still detected in
CaMV-infected plants deﬁcient in DCL1, which is
required for host miRNA biogenesis (dcl1-8, a
hypomorphic mutant). They were also detected in
infected plants deﬁcient in RDR2, RDR6 or both
RDR6 and RDR2 required for host siRNA biogenesis
(null mutants rdr2-1, rdr6-15 and double mutant rdr2/6)
(Figure 1A). Thus, a large fraction of sRNAs detected by
EtBr staining are likely to be vsRNAs of CaMV origin.
Nucleic Acids Research, 2011, Vol. 39, No. 12 5005
The 24-nt sRNA signal was abolished in the null
mutant dcl3-1, conﬁrming that the biogenesis of this
size-class of viral and host sRNAs is DCL3 depend-
ent (7,14).
To survey genome-wide interactions of CaMV with the
plant RNA silencing machinery we sequenced sRNA
populations from virus-infected wild-type and mutant
plants using Illumina technology (www.illumina.com).
The procedure selected for sRNAs with 50-phosphate
and 30-hydroxyl groups, i.e. DCL activity products.
Consistent with earlier reports (34,35), 81% of the
549 540 sRNA reads from mock-inoculated seedlings fell
into the 20–25 nt range, of which 75% mapped to the
Arabidopsis genome with zero mismatches; 24 nt and
21 nt reads were predominant (Figure 2A
and Supplementary Table S1). Likewise, 81% of the
1 470 760 reads from CaMV-infected plants fell into the
20–25 nt range, of which 40% mapped perfectly to
the Arabidopsis genome (120Mb) and 39% mapped
perfectly to the CaMV genome (8 kb) (Figure 1B,
Supplementary Table S1). Among 20–25 nt vsRNAs, the
24 nt fraction was largest (47%), while the 21 and 22 nt
fractions were second (27%) and third (14%) largest in
abundance (Figure 2B), respectively. This size-class distri-
bution agrees with our results for the relative abundance
of CaMV-derived sRNAs detected by blot hybridization
(14). To summarize the gel analysis and sequencing data
are in agreement and show that the vsRNA pool is com-
parable in size to the entire complement of host miRNAs
and siRNAs.
To investigate whether CaMV vsRNAs are redundantly
ampliﬁed by RDR activities known to mediate sRNA bio-
genesis (6), we generated a triple null mutant rdr1 rdr2
rdr6 (rdr1/2/6) and sequenced sRNAs from infected
rdr1/2/6 plants. In rdr1/2/6, 20–25 nt sRNAs perfectly
matching the CaMV genome represented 54% of
748 199 reads, while those perfectly matching the
Arabidopsis genome only represented 28% of the reads
(Supplementary Table S1 and Figure 1B). The decreased
percentage of host sRNAs in this mutant compared with
the wild-type resulted from a 10-fold decrease in
RDR2-dependent 24 nt sRNAs. In contrast to the pro-
ﬁle for host sRNAs, the proﬁle for vsRNAs did not
change signiﬁcantly in rdr1/2/6 relative to wild-type
(Figure 2B and Supplementary Table S1). From this,
we conclude that at the late stage of infection,
CaMV-derived vsRNAs are largely produced independ-
ently of RDR1, RDR2 and RDR6. We cannot,
however, exclude that CaMV vsRNAs can potentially be
ampliﬁed by these RDRs at the earlier stages of infec-
tion or under certain conditions. In RNA virus infec-
tions of Arabidopsis, vsRNAs are ampliﬁed by
Figure 1. Massive, RDR-independent generation of CaMV vsRNAs in infected Arabidopsis. (A) Total RNA from pools of CaMV-infected (+) or
mock-inoculated () wild-type control plants (Col-0 and Col-gl1) and mutants defective in host sRNA biogenesis: dcl2-5, dcl3-1, dcl4-2, rdr2-1,
rdr6-15 and rdr2 rdr6 (all in Col-0) and dcl1-8 (in Col-gl1). Plants were harvested 1-month post-inoculation or, in the case of dcl1-8, 2 months
post-inoculation. Total RNA was separated by 15% PAGE and then stained with ethidium bromide (EtBr). Lower and upper portions of the gels are
shown, the latter for RNA loading comparison. Positions of synthetic 21 and 24 nt RNA oligonucleotides and endogenous 102 nt U6 snRNA are
indicated. (B) Illumina deep-sequencing of sRNAs from mock-inoculated and CaMV-infected Arabidopsis wild-type (Col-0) and mutants (rdr1/2/6,
dcl1-8 and dcl2/3/4) conﬁrms massive production of RDR-independent vsRNA, comparable to the entire complement of host sRNAs. The graph
shows the percentage of Arabidopsis and vsRNAs in the pool of 20–25 nt reads mapped to the Arabidopsis and CaMV genomes with zero
mismatches.
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RDR1 and/or RDR6; this ampliﬁcation becomes most
evident when a viral silencing suppressor gene is
inactivated (8–11). The ability of the CaMV TAV
protein to interfere with host RDR6-dependent sRNA
pathways (19,20) could account for the lack of
RDR6-dependent vsRNAs in CaMV-infected plants.
Likewise, TAV may also inhibit production of
RDR1-dependent vsRNAs. It would be interesting to in-
vestigate whether a CaMV mutant deﬁcient for the
silencing suppressor activity of TAV can generate
RDR-dependent vsRNAs. However, the suppressor
activity would ﬁrst need to be genetically uncoupled
Figure 2. Illumina deep-sequencing analysis of CaMV sRNAs and comparative mappings of viral RNA molecules. Bar graphs showing the per-
centages of (A) Arabidopsis sRNAs and (B) vsRNAs in the pool of 20–25 nt sRNA reads sequenced from CaMV-infected wild-type (Col-0) and
mutant lines (rdr1/2/6, dcl1-8 and dcl2/3/4)—for number of reads, see Supplementary Table S1. (C) Genome-wide map of vsRNAs from
CaMV-infected Col-0 at single-nucleotide resolution. The graph plots the number of 20–25 nt vsRNA reads at each position of the 8031-bp
CaMV genome; the numbering starts at the 50-terminus of the 35S RNA (genome position 7434) as depicted in panel D. Bars above the axis
represent sense reads starting at each respective position; those below represent antisense reads ending at the respective position (Supplementary
Data). (D) cRT–PCR mapping of CaMV 8S RNA from virus-infected Arabidopsis (Supplementary Figure S4 for experimental details). The circular
CaMV genome organization is shown schematically with viral genes (boxes) and 35S and 19S promoters (dotted arrows) that drive Pol II tran-
scription of two major transcripts: the pregenomic 35S RNA and subgenomic 19 RNAs (depicted below the genome). The position and termini of the
CaMV leader region-derived 8S RNA species are indicated, as determined for sense and antisense polarities by cRT–PCR product sequencing.
Regions surrounding the 35S RNA start site and the 30-terminal part of the leader sequence preceding ORF VII are enlarged. The termini of
sequenced 8S RNA clones are indicated by arrows above the sequence for sense RNAs (42 clones) and below the sequence for antisense RNAs (36
clones). The number of clones is given when more than one clone had the same 50- or 30-terminus. Thick arrows indicate the major transcription start
site for sense 8S RNAs and the major 30-terminus for antisense 8S RNAs, which fall on the same genome position.
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from other TAV functions that are essential for viral
replication.
We also sequenced sRNAs from a hypomorphic mutant
deﬁcient for DCL1 (dcl1-8). In CaMV-infected dcl1-8,
viral reads outnumbered Arabidopsis genome-derived
reads due to the reduction in host miRNA accumulation
(Figure 1B and Supplementary Table S1). Of 20–25 nt
vsRNAs in dcl1-8, the fraction of 21 nt reads (17%) was
signiﬁcantly lower than that in wild-type plants (27%)
(Figure 2B). This conﬁrms our earlier ﬁnding that DCL1
contributes to the biogenesis of 21 nt vsRNAs (14). The
role of DCL1 in vsRNA biogenesis is also supported by
the sRNA sequence proﬁles we obtained for
CaMV-infected dcl2 dcl3 dcl4 triple null mutant (dcl2/3/
4) plants. The relative levels of 22 and 24 nt vsRNAs were
drastically reduced, whereas the relative level of 21 nt
vsRNA was increased compared to wild-type plants
(Figure 2B and Supplementary Table S1).
The distribution of 20–25 nt vsRNA reads across the
8031-bp CaMV genome was plotted at the
single-nucleotide scale (Figure 2C, Supplementary data
SD1, Supplementary Figures S1 and S2). These maps
show a biased distribution in terms of strand orientation
and position. First, 62% of reads from infected wild-type
plants matched the viral transcript polarity (i.e. sense
polarity). The sense-strand bias was also observed in the
mutant lines (Supplementary Table S1 and Supplementary
Figure S1). Second, both in wild-type and mutant plants, a
majority of viral reads, 65–82%, aligned to the 600-bp
leader region (Figure 2C, Supplementary Figure S1 and
Supplementary Table S1). Leader-speciﬁc reads are
distributed unevenly: several 50–80 nt ‘hot spots’ give
rise to most vsRNAs of either polarity. We found no cor-
relation of these hot spots with strong and regular second-
ary structures compatible with DCL binding and
processing. If unique vsRNA sequences are considered
(Supplementary Table S2), they densely tile across the
entire leader region in both polarities (Supplementary
Figure S2). Within hot spots, almost every nucleotide
position marks the 50-end of 21, 22 and 24 nt species,
each represented with up to several thousand reads
(Supplementary Figure S2 and Supplementary data
SD1). Similar hot spots were found in independent
samples from wild-type plants and in samples from rdr1/
2/6 and dcl2/3/4 plants. In dcl1-8, the hot spots were
shifted slightly (Supplementary Figures S1 and S2 and
Supplementary data SD1). Thus, in the absence of a
fully functional DCL1, other DCLs process vsRNA pre-
cursors with somewhat altered sequence speciﬁcity.
We validated the deep-sequencing data by RNA blot
hybridization using 36-short DNA oligonucleotide
probes speciﬁc to CaMV (Supplementary Table S3) and
conﬁrmed a reproducible pattern of vsRNA hot spots
covering the leader region in both polarities
(Supplementary Figure S3). Both approaches reveal the
hot spots in the same zones within the leader region. In
contrast, only very low levels of vsRNAs could be detected
with probes speciﬁc to the 35S promoter region upstream
of the leader (Supplementary Figure S3), which also agrees
with our deep-sequencing data (Supplementary data SD1).
Genetic requirements for vsRNA biogenesis were found to
be similar throughout the leader region (Supplementary
Figure S3). Together, our blot hybridization and
sequencing data indicate that each of the four DCLs
processes a leader-length dsRNA precursor or, alterna-
tively, multiple overlapping dsRNAs derived from the
entire leader. This dsRNA processing appears to be
initiated internally and sporadically, but with some pref-
erence for the hot spots. It is also possible that differential
vsRNA stability contributes to hot spot formation. No
phasing could be discerned that would resemble process-
ing of trans-acting siRNAs from RDR6-dependent
dsRNA (28).
The robust systemic infection and viral DNA accumu-
lation that we observed in spite of massive vsRNA pro-
duction was surprising. In the case of RNA viruses, strong
suppressor proteins such as a potyviral HC-Pro are known
to inactivate vsRNAs (5,11). However, this is not sufﬁ-
cient to explain our observations for CaMV, which does
not encode a strong suppressor protein. The CaMV TAV
protein is a weak silencing suppressor that perturbs
RDR6-dependent pathways associated with sRNA ampli-
ﬁcation (18–20). Furthermore, CaMV infection does not
suppress transgene silencing triggered by RDR6-
independent dsRNA (20). To test whether massively
produced CaMV vsRNAs have an antiviral function, we
generated two dcl1 dcl2 dcl3 dcl4 (dcl1/2/3/4) quadruple
mutants each carrying a hypomorphic allele of DCL1
(dcl1-8 or dcl1-9) and null alleles of DCL2, DCL3 and
DCL4. RNA blot hybridization showed that, compared
to triple mutant dcl2/3/4, both quadruple mutants
accumulated only residual 21 nt vsRNAs (Figure 3A and
Supplementary Figure S3). The truncated DCL1 protein
encoded by dcl1-9 mutant alleles can process miRNA pre-
cursors, but less efﬁciently and precisely than wild-type
DCL1 (36). This leads to destabilization of most
miRNAs, including miR173 but excluding miR168 (37):
we used these two miRNAs as controls (Figure 3A).
RNA viruses have been shown to accumulate at higher
levels in dcl1/2/3/4 plants (13). In contrast, titers of CaMV
DNA and polyadenylated 35S and 19S transcripts were
not affected substantially in dcl1/2/3/4 or dcl2/3/4 as
measured by real-time qPCR and qRT–PCR, respectively
(Figure 3B), and by other methods (Supplementary Figure
S4). This extends our ﬁnding that CaMV DNA accumu-
lation is not dramatically affected in any of the four single
dcl mutants (14), and is in contrast to Moissiard and
Voinnet (16) who observed a strong increase in accumu-
lation of CaMV 35S RNA and coat protein in dcl2/3/4
compared to wild-type plants. The fact that distinct strains
of CaMV were studied—CM1841 in our case and JI in
(16)—may account for this discrepancy. In different
CaMV strains, the TAV protein is known to be a deter-
minant of host range and symptom severity. TAV
function in suppressing RNA silencing-based host
defenses may also be strain dependent.
Stability and function of Arabidopsis sRNAs depend on
their incorporation into an RNA-induced silencing
complex (RISC) through binding to AGO proteins that
sort sRNAs based on their 50-nt and size (38–40). Thus, a
majority of 21 nt miRNAs have 50 uridine (50U)-termini
and associate with AGO1, whereas a large fraction of
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24 nt siRNAs have 50 adenosine (50A)-termini and associ-
ate with AGO4. In line with this, in our data sets,
we found that 21 nt host sRNAs predominantly have
50U (78% of the total 21 nt reads; Supplementary Table
S1), whereas 24 nt host sRNAs predominantly have 50A
(60% of the total 24 nt reads). In contrast, 29% of 21 nt
viral sRNAs have 50U-termini and 41% have 50A-termini
(Supplementary Table S1), which would predict their as-
sociation with AGO1 and AGO2, respectively (37). We
previously observed an up-regulation of AGO2 and
AGO7 but not other AGO genes in CaMV-infected
plants (20). Because AGO7 interacts speciﬁcally with
miR390 (39), increased availability of AGO2 protein is
more likely to account for preferential accumulation of
50A vsRNAs. AGO2 binds vsRNAs derived from
Cucumber mosaic virus, which is an RNA virus (40), but
no functions of AGO2 in antiviral defense or silencing of
host genes are known.
In principle, CaMV derived 24 nt vsRNAs with
50A-termini (35% of the total 24 nt reads;
Supplementary Table S1) could associate with AGO4 to
mediate viral DNA methylation. In addition to AGO4,
the host siRNA-directed de novo methylation pathway
depends on the RNA polymerases Pol IV and Pol V and
the chromatin remodeling factor DRD1 (26,41). Our
earlier studies showed that deﬁciencies in AGO4 and Pol
IV do not affect CaMV DNA accumulation and only
slightly affect vsRNA accumulation (14); we conﬁrmed
this result here using drd2-4, a different loss-of-function
mutant for Pol IV (Supplementary Figure S5). Similarly,
we did not ﬁnd drastic changes in CaMV DNA and
vsRNA accumulation caused by deﬁciencies in Pol V or
DRD1 (drd3-7 and drd1-6, respectively) (Supplementary
Figure S5). These ﬁndings and the fact that CaMV
DNA is actively transcribed throughout the infection
cycle (42) strongly suggest that the de novo methylation
pathway is not a major player in CaMV silencing. In line
with this, we found very little vsRNAs derived from the
35S promoter region in CaMV-infected plants
(Supplementary Figure S3 and our Illumina data).
Moreover, only negligible amounts of leader-derived
vsRNAs and no vsRNAs from promoter and coding
regions were detected bound to the AGO4 protein in
our immunoprecipitation (IP) assay with native antibodies
for AGO4 (Supplementary Figure S5).
The massive production of vsRNAs of both polarities
from the 35S RNA leader region suggests that sense and
antisense transcripts covering just this region could be
their precursors. Such sense RNA was described earlier
as a viral 8S RNA of unknown function (17). By using
cRT–PCR (31), we isolated multiple species of 8S RNA
from CaMV-infected wild-type or dcl2/3/4 Arabidopsis
plants (Figure 2D and Supplementary Figure S6). The
8S RNA starts at either of two consecutive AC-motifs,
the ﬁrst of which was reported as the common start site
of 35S and 8S RNAs (17), but ends heterogeneously close
to the primer binding site of RT located at the end of the
leader sequence (Figure 2D). At this position, the virion
CaMV DNA has a discontinuity of the minus (antisense)
strand marking the start and the end of RT (21). Abrupt
termination of 35S promoter-directed transcription close
Figure 3. CaMV vsRNAs and DNA/RNA titers detected in quadruple
dcl-mutants. (A) Analysis of low-molecular weight RNA extracted from
pools of CaMV-infected (+) or mock-inoculated () plants: wild-type
(Col-0), triple dcl-mutant (dcl2/3/4) and two quadruple dcl-mutants
carrying weak dcl1 alleles (dcl1/2/3/4-sin, dcl1/2/3/4-caf).
Size-fractionated RNA was analyzed by 18% PAGE followed by blot
hybridization. The membrane was successively hybridized with sense
and antisense DNA oligonucleotide probes for the CaMV leader
region, and probes for host sRNAs: miR173 (22 nt), miR168 (21 nt),
siR255 (21 nt), siR1003 (24 nt). Met-tRNA (72 nt) serves as a loading
control. Sizes are indicated on each data image. (B) Viral titers in
CaMV-infected wild-type (Col-0), dcl2/3/4 and dcl1/2/3/4-caf were
measured using quantitative real-time PCR (qPCR) for viral DNA
and qRT–PCR for polyadenylated 35S and 19S transcripts (see
‘Materials and Methods’ section). In both cases, PCR primers speciﬁc
for the CaMV leader-region and the CaMV TAV region
(Supplementary Table S3) were used in parallel for each sample. As
internal controls, we performed qPCR and qRT–PCR on the same
DNA and cDNA samples with primers speciﬁc for 18S rDNA and
ACT2 gene, respectively (Supplementary Table S3). The mean of the
normalized levels for viral DNA and RNA (the sum of 35S and 18S
RNAs) is shown; the CaMV titer in wild-type (Col-0) plants was set to
one in each case.
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to the discontinuity of the unsealed DNA template in the
nucleus might lead to accumulation of sense 8S RNA.
Alternatively, sense 8S RNA that folds into an extended
hairpin structure (see below) may be processed from 35S
RNA by ‘Drosha’-like activity of DCL1 (36) as suggested
previously (16).
Using cRT–PCR with reverse primers, we found
multiple antisense copies of 8S RNA. These antisense
transcripts start around the positions of the 30-ends of
sense 8S RNAs and end precisely at the sense 8S RNA
start site, essentially mirroring sense 8S RNAs (Figure 2D
and Supplementary Figure S6). We propose that sense and
antisense 8S RNAs form dsRNAs that are then processed
by DCLs to generate vsRNAs. Both sense and antisense
8S RNAs lack a poly(A) tail and are sensitive to
pyrophosphatase (Supplementary Figure S6), suggesting
that they are either capped or 50-triphosphorylated. The
heterogeneity of the 50-termini and the lack of adequately
positioned promoter consensus sequences in antisense
orientation argue against production of antisense 8S
RNA on a CaMV DNA template. On the other hand,
our mapping data are consistent with a model, in which
8S RNA sense transcripts are converted into dsRNAs by
an RNA-directed RNA polymerase activity. This poly-
merase would drop off at the 50-end of the template
without adding extra non-template nucleotides. Our
genetic evidence excludes RDR1, RDR2 and RDR6 as
well as Pol IV and Pol V as this enzyme, because
wild-type amounts of CaMV leader-derived vsRNAs of
both polarities accumulated in rdr1/2/6 (see above) as
well as in the loss-of-function mutants for Pol IV [(14),
(Supplementary Figure S5; drd2-7 and nrpd2a-1)] and Pol
V (Supplementary Figure S5; drd3-7 and nrpd2a-1).
Formally, we cannot exclude a possibility that three add-
itional genes of the Arabidosis RDR family, for which no
function was reported so far (6), may be involved.
Another, more likely, candidate would be Pol II. Pol II
is known to replicate animal hepatitis delta virus and plant
RNA viroids, circular single-stranded RNAs that form
extensive secondary structures (43). The CaMV leader
sequence forms such a viroid-like structure (23).
Furthermore, Lipardi and Paterson (44) have reported
that the largest subunit of Drosophila Pol II has an
RDR activity and participates in RNA silencing and
transposon suppression.
Despite the hindrance to translation initiation on viral
35S RNA due to the presence of a highly structured
leader, the approximate size and secondary structure,
but not the primary sequence of the leader region are
highly conserved in diverse plant pararetroviruses (45).
Furthermore, most mutations and second site reversions
in the CaMV leader primary sequence have little effect on
virus replication (25,46,47). These considerations and the
fact that a complex shunt mechanism has evolved to allow
scanning ribosomes to bypass the leader (22,25,45) suggest
that there is a selective advantage for a long, highly
structured leader.
One possibility is that the complexity and length of the
leader are required for the function of polyadenylation,
packaging and splicing signals that it contains; but, this
seems unlikely because these signals require much less
space and structure in other DNA viruses. Another pos-
sibility is that the vsRNAs produced from the leader
region play a role in viral counter-defense. Moissiard
and Voinnet (16) have proposed that the CaMV leader
forms a miRNA precursor-like structure and some
leader-derived vsRNAs target host genes in a
sequence-speciﬁc manner to the advantage of the virus.
Our transcriptome proﬁling of CaMV-infected plants
and of transgenic plants expressing CaMV TAV protein
(20) revealed only modest downregulation of some pre-
dicted target genes, which appears to depend on CaMV
TAV expression rather than vsRNAs per se
(Supplementary Figure S7). The fact that the leader
primary sequence is not evolutionary conserved also
argues against a sequence-speciﬁc role for leader-derived
vsRNAs in viral counter-defense.
More consistent with our data is a hypothesis that the
8S duplex RNA derived from the leader region acts as a
silencing decoy to engage all four DCLs in massive pro-
duction of vsRNAs. These highly abundant vsRNAs
could prevent less abundant vsRNAs produced from
other CaMV genome regions from being assembled into
AGO–RISCs. Our ﬁnding that CaMV titers are not
affected in the dcl1/2/3/4 mutants, in which both the
host defense and the viral leader-based counter-defense
are undermined, indicates that sporadic production of
vsRNAs outside of the leader region does not contribute
substantially to restricting virus replication. Thus, in the
wild-type plants, these less abundant vsRNAs do not
appear to form sufﬁcient amounts of active AGO–
RISCs to silence viral transcripts. To test this hypothesis,
we analyzed vsRNAs associated with AGO1, the major
AGO effector protein implicated in antiviral defense
(48–51). IP of AGO1 from CaMV-infected plants with a
speciﬁc native antibody (49) yielded a sample highly
enriched with leader-derived vsRNAs, whereas vsRNAs
derived from other CaMV genome regions were not
detected (Figure 4).
AGO–RISCs charged with leader-derived vsRNAs of
antisense polarity could potentially target 35S RNA.
However, the leader sequence of 35S RNA forms a
stable secondary structure required for both translation
(25,47) and packaging/RT (24) and this structure would
prevent RISC binding. In line with this, our previous
studies indicate that stability and integrity of the leader
secondary structure correlates with CaMV infectivity
(25,46,47). Studies of viroids and viral satellites and
defective-interfering RNAs have shown that although
vsRNAs can be produced from such precursors (presum-
ably during replication when they spawn dsRNAs), their
secondary structures largely prevent them from being
targeted by the resulting vsRNAs (10,52–55).
Massively produced vsRNAs could potentially compete
with host miRNAs and siRNAs for free AGO proteins,
interfering with endogenous RISC function. But our
AGO-IP experiments do not support this idea: binding
of miR173 to AGO1 and the AtREP2 siRNAs to AGO4
was not perturbed by CaMV infection (Figure 4 and
Supplementary Figure S5). Accordingly, our previous
study indicates that CaMV infection and CaMV TAV ex-
pression do not interfere with miR173-directed cleavage of
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target transcripts (20). Moreover, our transcriptome
proﬁling did not reveal a general upregulation of
miRNA-targeted transcripts upon CaMV infection,
except for those silenced by RDR6-dependent secondary
siRNAs; the latter effect is attributable to the silencing
suppressor activity of CaMV TAV protein (20). Thus
AGO-RISCs programmed by host miRNAs and siRNAs
do not appear to be perturbed by massive production of
vsRNAs. Therefore, leader-derived 8S dsRNA/vsRNAs
cannot be considered as a general decoy that interferes
with all RNA silencing pathways. Instead, massive pro-
duction of vsRNAs from the leader region may divert the
silencing machinery from targeting the most vulnerable
CaMV regions, i.e. viral promoters and unstructured
coding regions of 19S and 35S transcripts.
The CaMV leader-based cis-elements and structures are
essential for viral replication and therefore the leader
sequence cannot be deleted from or replaced by a heter-
ologous leader in CaMV genome without drastically af-
fecting CaMV infectivity (25,46,47). To provide further
evidence for our decoy hypothesis, we therefore expressed
leader-derived vsRNAs ectopically from a heterologous
DNA virus. We made use of an attenuated geminivirus,
Cabbage leaf curl virus (CaLCuV), lacking the coding
sequence of its coat protein gene (33). The CaMV leader
sequence was inserted between the CaLCuV Pol II
promoter and terminator in place of the coat protein
gene. If massively produced leader-derived vsRNAs
would be antiviral, infectivity and DNA accumulation of
the resulting chimeric virus should be reduced. In contrast,
the chimeric virus exhibited increased infectivity on
Arabidopsis and accumulated measurably higher DNA
titers than the CaLCuV vector control or the vector
carrying a non-viral insert of similar length (green ﬂuor-
escent protein gene sequence of 714 bp; GFP) (Figure 5A).
Plants infected with the CaLCuV::CaMV leader chimera
accumulated high levels of 21–24 nt vsRNAs from the
inserted CaMV leader region, which were comparable to
the levels of leader-derived vsRNAs accumulating in
Figure 5. Ectopic expression of CaMV leader-derived vsRNAs from an
attenuated geminivirus slightly increases viral DNA accumulation.
(A) Viral DNA titers in Arabidopsis plants infected with a CaLCuV
vector carrying the CaMV leader sequence (CaLCuV-CamvL) versus
the vector control virus (CaLCuV-vec) or the vector carrying a
non-viral insert (CaLCuV-GFP) were measured by semi-quantitative
PCR on serial dilutions (5-fold each) of total DNA isolated from
pools of three to four infected or mock-inoculated plants. 18S riboso-
mal DNA ampliﬁcation is an internal control. The titers were also
conﬁrmed by qPCR. (B) vsRNAs were analyzed by RNA blot hybrid-
ization using total RNA from pools of three to four virus-infected
(CaMV, CaLCuV-vec, CaLCuV-CamvL and CaLCuV-GFP) or
mock-inoculated plants. The membrane was successively hybridized
with DNA oligonucleotide probes for the CaMV leader region and
CaLCuV AC4 gene. Met-tRNA is shown as a loading control. Note
that two independent clones of the CaLCuV-CamvL construct were
analyzed.
Figure 4. Preferential loading of CaMV leader-derived vsRNAs into
AGO1 and the effect of CaMV infection on accumulation of AGO1
protein and AGO1-associated miRNA. The upper panel shows RNA
blot hybridization analysis of total sRNAs (input) and sRNAs
associated with AGO1 protein in mock-inoculated () or
CaMV-infected (+) plants following immunoprecipitation with
AGO1-speciﬁc antibodies (IP:AGO1) or normal rabbit serum
(IP:NRS) as a negative control. The membrane was successively
hybridized with mixtures of non-overlapping sense and antisense
DNA probes speciﬁc for the CaMV leader region (CaMV leader mix)
or the CaMV 35 promoter and ORF VII/I regions (CaMV
promoter+ORF mix) and the probe speciﬁc for miR173 (22 nt)
(Supplementary Table S3). The lower panel shows western blot
analysis of AGO1 protein accumulation in the input and the
IP:AGO1 fractions using AGO1-speciﬁc antibodies (@AGO1). The
blot was also stained with antibodies speciﬁc for CaMV TAV protein
(@TAV).
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CaMV-infected plants (Figure 5B). VsRNAs from the
CaLCuV genome also accumulated, albeit at lower levels
(Figure 5B). The accumulation of the CaLCuV
genome-speciﬁc vsRNAs from the CaLCuV::CaMV
leader chimeric virus was slightly higher than for the
case of the CaLCuV empty vector and CaLCuV::GFP
control virus, which correlates with their respective viral
DNA titers. Thus, despite the production of CaMV
leader-derived vsRNAs in addition to CaLCuV-speciﬁc
vsRNAs, replication of the chimeric virus was not
reduced. These data are consistent with our decoy
hypothesis.
CONCLUSIONS
Here, we demonstrate that CaMV infection is associated
with massive production of RDR1-/RDR2-/RDR6-
independent vsRNAs from the leader region, whereas
other regions of the viral genome spawn only low
amounts of vsRNAs. The quantity of leader-derived
vsRNAs is comparable to the entire complement of en-
dogenous plant miRNAs and siRNAs. Illumina
sequencing of vsRNAs revealed several hot spots
matching both polarities of the leader region. Likely
precursors of these vsRNAs are long double-stranded
molecules arising from Pol II transcription of the entire
leader region into sense and antisense 8S RNAs, which we
detected by cRT–PCR. Genetic evidence indicates that all
four DCLs process vsRNAs from their precursors. This
processing occurs internally with some preference for hot
spot sequences, but differential vsRNA stability may also
account for hot spot formation.
CaMV titers were not elevated in dcl-quadruple
mutants, despite vsRNA levels being greatly diminished.
Thus, massive vsRNA production in wild-type plants does
not appear to restrict viral replication. Furthermore,
ectopic expression of CaMV leader vsRNAs from an
attenuated geminivirus did not render the chimeric virus
more prone to plant antiviral defenses. These results raise
the possibility that in addition to expressing the silencing
suppressor protein TAV that interferes with RDR-
dependent ampliﬁcation of siRNAs (18–20), CaMV
deploys counter-defense based on decoy 8S dsRNA
generated from the non-coding leader region (Figure 6).
Massive production of primary vsRNAs from 8S dsRNA
might divert silencing effectors from targeting CaMV pro-
moters and unstructured transcripts outside of the leader
region. AGO1 is a major effector of antiviral silencing in
Figure 6. Model for CaMV interactions with the Arabidopsis sRNA-generating machinery. Viral DNA is released from the virion into the nucleo-
plasm. Gaps in this DNA left by RT during the previous replication cycle are repaired by host DNA repair enzymes to create covalently closed
molecules. Closed viral DNA is transcribed by Pol II into pregenomic 35S RNA, which is a polycistronic mRNA for several viral proteins including
RT and a template for RT. Viral DNA is also transcribed by Pol II into subgenomic 19S RNA, which is the mRNA for the viral transactivator/
viroplasmin protein (TAV). Abrupt termination of Pol II-driven transcription, potentially caused by an unrepaired DNA gap (Met-tRNA gap),
results in production of aberrant 8S RNAs lacking poly(A) tails. This 8S RNA matches the 35S RNA leader sequence, and is predicted to form a
viroid-like secondary structure, which may be converted to dsRNA by Pol II. We hypothesize that 8S RNA-derived dsRNA serves as a decoy to
engage all four DCLs in massive production of 21, 22 and 24 nt vsRNAs. These leader-region vsRNAs would compete with vsRNAs derived from
other regions for AGO proteins. Resulting antisense vsRNAs would potentially guide AGO-meditated silencing of 35S RNAs, but the structured
nature of the leader would likely hinder vsRNA pairing. Sporadic cleavage products of 35S or 19S RNA enter sRNA biogenesis pathways (evidenced
by low-level vsRNA biogenesis from these regions), but host RDR6-dependent processes are suppressed by viral TAV protein (19,20).
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plants, which explains why RNA viruses express suppres-
sor proteins that target AGO1 for degradation, reduce
AGO1 protein translation, or disrupt its RNA cleavage
activity (5,48–51). Unlike RNA viruses, CaMV infection
did not perturb AGO1 accumulation, its association with
endogenous miRNAs or activity. The fact that
leader-derived vsRNAs were associated with AGO1,
whereas vsRNAs from other regions of CaMV genome
were not detected in the AGO1 complexes, lends further
support to our decoy model of CaMV counter-defense
(Figure 6).
It will be interesting to explore whether other plant
viruses use decoy RNAs to evade silencing. Studies on
human adenovirus found that highly structured viral
RNAs suppress the interferon-mediated antiviral defense
and sequester Dicer (56). Thus an RNA decoy strategy to
counteract antiviral defense may be common among plant
and animal viruses.
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